Ebola Study Shows Consistent Immune Inhibition by Different Ebola Virus Strains
NIH scientists have added new molecular evidence that the Ebola virus (EBOV) circulating in West Africa since late 2013 is no more virulent than EBOV seen in previous outbreaks. Using more than 100 different published EBOV genome sequences, they compared the roles of two EBOV proteins known to suppress production of interferon, a naturally produced virus fighter. In every study measurement the proteins acted in the same way regardless of being derived from the current outbreak strain or strains from prior outbreaks.
No hay comentarios:
Publicar un comentario